COVID-19: Production capacity of Remdesivir increased to nearly 119 lakh vials per month, says Govt ANI | Updated: May 17, 2021 17:33 IST
New Delhi [India], May 17 (ANI): With the sudden increase of cases during the second wave of the pandemic, the government has taken swift actions to enhance the availability of an anti-viral drug Remdesivir across the country. Presently, nearly 119 lakh vials of Remdesivir are being produced per month, the Department of Pharmaceuticals informed on Monday.
The department has, ever since, intensified the monitor on the availability, production and supply of Remdesivir. This has resulted in a substantial increase in the number of manufacturing sites of Remdesivir.
The Union government has made an interim allocation of tocilizumab among the states, as a fresh limited stock of the drug used for the treatment of COVID-19 patients has arrived in the country. In a letter, Pharma Joint Secretary Navdeep Rinwa and Health and Family Welfare Ministry Director Rajiv Wadhawan said the drug went out of stock in the country a few weeks ago due to a sudden surge in its demand because of a sharp rise in COVID-19 cases in the country. Fresh limited stock of this drug has now been imported and is available with lone marketer company Cipla Ltd formarketing and distribution in the country, the letter said.
Govt makes interim allocation of COVID-19 treatment drug Tocilizumab to states
Fresh limited stock of this drug has now been imported and is available with lone marketer company Cipla Ltd for marketing and distribution in the country, the letter said.
Share Via Email
| A+A A- By PTI
NEW DELHI: The Union government has made an interim allocation of Tocilizumab among the states, as a fresh limited stock of the drug used for the treatment of COVID-19 patients has arrived in the country.
In a letter, Pharma Joint Secretary Navdeep Rinwa and Health and Family Welfare Ministry Director Rajiv Wadhawan said the drug went out of stock in the country a few weeks ago due to a sudden surge in its demand because of a sharp rise in COVID-19 cases in the country.